Chargement en cours...

CTLA-4 Blockade with Ipilimumab: Long-Term Follow-up of 177 Patients with Metastatic Melanoma

PURPOSE: Treatment with ipilimumab can cause objective tumor responses in patients with metastatic melanoma. We have treated 177 evaluable patients in three clinical trials and have long-term follow-up to evaluate the durability of responses. PATIENTS AND METHODS: Patients with metastatic melanoma w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Prieto, Peter A., Yang, James C., Sherry, Richard M., Hughes, Marybeth S., Kammula, Udai S., White, Donald E., Levy, Catherine L., Rosenberg, Steven A., Phan, Giao Q.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319861/
https://ncbi.nlm.nih.gov/pubmed/22271879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1823
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!